Vascular disease in diabetes: pathophysiological mechanisms and therapy
- 1 February 1979
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 139 (2), 225-230
- https://doi.org/10.1001/archinte.139.2.225
Abstract
Vascular disease is the major cause of morbidity and mortality in diabetes mellitus. Diabetics are twice as prone to heart attacks, 5 times more prone to gangrene, 17 times more prone to kidney failure and 25 times more prone to blindness than nondiabetics. This reflects the effects of accelerated atherosclerosis, plus a relatively specific form of microvascular disease in multiple organ systems in the diabetic. Recent progress has been made in the understanding of the mechanisms involved both in large-vessel disease (macrovascular disease) and small-vessel disease (microvascular disease) in patients with diabetes mellitus. With an increased understanding of the mechanisms involved, intelligent decisions about therapy may be more easily made. Current thoughts about the pathophysiologic features of diabetic vascular disease are reviewed and therapeutic recommendations are made.This publication has 17 references indexed in Scilit:
- Plasma Cofactors of Platelet Function: Correlation with Diabetic Retinopathy and Hemoglobins Ala-cAnnals of Internal Medicine, 1978
- Correlation of platelet aggregation, plasma factor activity, and megathrombocytes in diabetic subjects with and without vascular diseaseMetabolism, 1977
- In vivo platelet function in diabetes mellitusThrombosis Research, 1976
- Persistence of thromboxane A2-like material and platelet release-inducing activity in plasma.Journal of Clinical Investigation, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- The Pathogenesis of AtherosclerosisNew England Journal of Medicine, 1976
- Increased Platelet Aggregation in Early Diabetus MellitusAnnals of Internal Medicine, 1975
- Role of Insulin in Endogenous Hypertriglyceridemia*Journal of Clinical Investigation, 1967
- Platelet adhesiveness in diabetes mellitusJournal of Clinical Pathology, 1967
- Increased Activity of “Anti-Willebrand Factor” in Diabetic PlasmaThrombosis and Haemostasis, 1964